MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Virtual Reality EEG guided motor neurofeedback training has mid-term effects in Parkinson’s Disease Patients limits of stability

    JP. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, M. Gil, E. Sanz, P. Serrano, E. Rodriguez (Madrid, Spain)

    Objective: To prove the effects of a virtual reality (VR) EEG guided motor Neurofeedback (NFB) training protocol on stability and gait of non-demented HY I-III…
  • 2019 International Congress

    Predicting the functional impact on the performance of daily activities in people with PD: a novel approach based on objective measures obtained by inertial sensors

    K. Lebel, C. Duval, E. Goubault, S. Bogard, P. Blanchet (Montreal, QC, Canada)

    Objective: To predict global motor disabilities using symptomatology assessed with inertial sensors, medication regimen, and cognitive deficits through: (1) a clustering method on performance metrics…
  • 2019 International Congress

    Design and Baseline Characteristics of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study

    S. Chung, M. Garriga, M. Ceravolo, N. Tambasco, W. Robieson, M. Facheris, O. Sánchez-Soliño, L. Barbato (Seoul, Republic of Korea)

    Objective: To evaluate the effectiveness of levodopa-carbidopa intestinal gel, LCIG (known as carbidopa-levodopa enteral suspension in the US), on non-motor symptoms (NMS) compared with optimized…
  • 2019 International Congress

    Effects of Virtual Reality Exercise Program using the Sony PlayStation 2 gaming platform on Balance, Emotion and Quality of Life in Patients with Parkinson’s Disease

    G-H. Lee (Cheonan, Republic of Korea)

    Objective: This study was to investigate the effectiveness of a 12-week virtual reality(VR) exercise program designed around low-cost VR device, the Sony PlayStation 2 (PS2) gaming…
  • 2019 International Congress

    Management of Akinesia in Parkinson’s Disease with Apomorphine Subcutaneous Injection

    F. Rakhimov, B. Sultanov (Tashkent, Uzbekistan)

    Objective: To assess the effect of apomorphine on time-to-ON in PD patients with morning akinesia. Background: In patients with motor fluctuations complicating Parkinson's disease (PD), delays in time-to-ON…
  • 2019 International Congress

    Imaging Parkinson’s disease pathology: A comparison between neuromelanin-sensitive MRI, susceptibility weighted imaging and [11C]PE2I DAT PET

    A. Chandra, G. Pagano, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

    Objective: We compared 2 novel MRI techniques: neuromelanin-sensitive MRI (NM-MRI) and susceptibility weighted imaging (SWI) with [11C]PE2I PET in order to establish their validity as biomarkers…
  • 2019 International Congress

    The effect of ADORA2A gene polymorphism on the dyskinesia of Parkinson’s Disease

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil, N. Imamova, A. Cinar Kuskucu (Istanbul, Turkey)

    Objective: To investigate the relationship of levodopa-induced dyskinesia with ADORA2A gene polymorphisms in PD patients. Background: With the progression of the disease, motor complications and…
  • 2019 International Congress

    Genetic panel testing in Parkinson’s disease

    T. Toomsoo, I. Rubanovich, I. Kalju, S. Ott, A. Lindmäe, M. Mällo, K. Jaakson, K. Joost, K. Vender (Tallinn, Estonia)

    Objective: To evaluate effectiveness of panel testing of known Parkinson's disease (PD) related genes in clinical practice. Background: It is widely recognised that monogenic forms…
  • 2019 International Congress

    Sleep Aspects on Video-Polysomnography in P.A53T SNCA Mutation Carriers

    AM. Simitsi, C. Koros, M. Stamelou, D. Papadimitrioy, A. Bougea, I. Pachi, N. Papagiannakis, R. Antonelou, E. Angelopoulou, K. Lourentzos, L. Stefanis, A. Bonakis (Athens, Greece)

    Objective: To determine whether REM sleep behavior disorder (RBD) and other sleep abnormalities occur in carriers of the p.A53T alpha-synuclein gene (SNCA) mutation, the prototypical…
  • 2019 International Congress

    Transcranial sonography in carriers of Gaucher disease

    F. Omrani, N. Mohammadzade, M. Rohani, Z. Omrani, B. Zamani (Tehran, Islamic Republic of Iran)

    Objective: The objectives are to  compare maximal area of SN hyperechogenicity (aSNmax) and diameter of third ventricle (DTV) between GBA mutation carriers and healthy controls.…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley